Cargando…
SARS-CoV-2 vaccines for cancer patients: a call to action
Coronavirus disease 2019 (COVID-19) has affected more than 96 million people worldwide, leading the World Health Organization (WHO) to declare a pandemic in March 2020. Although an optimal medical treatment of COVID-19 remains uncertain, an unprecedented global effort to develop an effective vaccine...
Autores principales: | Corti, Chiara, Crimini, Edoardo, Tarantino, Paolo, Pravettoni, Gabriella, Eggermont, Alexander M.M., Delaloge, Suzette, Curigliano, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904467/ https://www.ncbi.nlm.nih.gov/pubmed/33770576 http://dx.doi.org/10.1016/j.ejca.2021.01.046 |
Ejemplares similares
-
Therapeutic vaccines for breast cancer: Has the time finally come?
por: Corti, Chiara, et al.
Publicado: (2022) -
Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!
por: Curigliano, Giuseppe, et al.
Publicado: (2021) -
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials
por: Trillo Aliaga, Pamela, et al.
Publicado: (2021) -
Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021) -
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
por: Crimini, Edoardo, et al.
Publicado: (2022)